PharmaSGP Holding SE Logo

PharmaSGP Holding SE

PSG | F

Overview

Corporate Details

ISIN(s):
DE000A2P4LJ5
LEI:
3912005CZ12PVVCIPT91
Country:
Germany
Address:
Lochhamer Schlag 1, 82166 Gräfelfing
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products. Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers. In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany. Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 12:00
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,315 additional shares…
English 6.8 KB
2025-08-11 13:00
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 39,678 additional share…
English 6.8 KB
2025-08-08 11:47
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 873 additional shares o…
English 6.8 KB
2025-08-07 13:11
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,505 additional shares…
English 6.8 KB
2025-08-06 16:16
Delisting Announcement
PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchan…
English 7.8 KB
2025-08-05 10:48
Director's Dealing
PharmaSGP Holding SE: Michael Rudolf, Tender of 4,169 shares within the public …
English 5.9 KB
2025-08-04 13:58
Delisting Announcement
PharmaSGP Holding SE: Dr. Clemens Fischer, Tender of a total of 6,062 addition…
English 6.6 KB
2025-07-28 17:04
Delisting Announcement
PharmaSGP Holding SE publishes joint reasoned statement of the Management Board…
English 9.2 KB
2025-07-28 14:11
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of an additional total of 4,491 share…
English 6.9 KB
2025-07-24 15:30
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, buy
English 6.0 KB
2025-07-24 14:11
Delisting Announcement
FUTRUE GmbH submits request to implement squeeze-out of minority shareholders o…
English 8.2 KB
2025-07-23 17:38
Declaration of Voting Results & Voting Rights Announcements
English 13.0 KB
2025-07-23 17:15
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 540 shares in PharmaSGP…
English 6.6 KB
2025-07-18 11:57
Delisting Announcement
PharmaSGP Holding SE: Acceptance period for FUTRUE GmbHs public delisting tende…
English 7.2 KB
2025-07-11 08:01
Earnings Release
PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025
English 8.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-25 FUTRUE GmbH Close relation Buy None 12,145,250.00 EUR
2022-10-05 MMI Leisure & Capital Management GmbH Close relation Buy None 125,383.20 EUR
2022-10-05 Hillen, Ingo Board Buy None 1,048.00 EUR
2022-10-05 MMI Leisure & Capital Management GmbH Close relation Buy None 26.60 EUR
2022-05-30 Wittig, Dr. Thomas Supervisory board Buy None 138,953.80 EUR
2022-05-30 Schröter, Jasmin Close relation Buy None 119,660.00 EUR
2022-05-30 Simon-Schröter, Dr. Wolfram Other Buy None 10,040.00 EUR
2022-04-25 FUTRUE GmbH Close relation Buy None 208,180.53 EUR
2022-04-25 MMI Leisure & Capital Management GmbH Close relation Sell None 197,193.60 EUR
2022-04-25 Bloching, Prof. Dr. Micha Supervisory board Sell None 171,825.00 EUR

Peer Companies

Company Country Ticker View
Biotika A.S. Logo Biotika A.S. Slovakia BSL
Bio Vitos Pharma AB Logo Bio Vitos Pharma AB Sweden BIOVIT
BOIRON Logo BOIRON France BOI
Bonyf N.V. Logo Bonyf N.V. Belgium MLBON
Bosnalijek d.d. Sarajevo Logo Bosnalijek d.d. Sarajevo Bosnia and Herzegovina BSNL
BrightPath Biotherapeutics Co., Ltd. Japan 4594
Calliditas Therapeutics Logo Calliditas Therapeutics Sweden CALTX
Camurus Logo Camurus Sweden CAMX
CanBas Co.,Ltd. Japan 4575
Cannabotech Ltd. Logo Cannabotech Ltd. Israel CNTC